Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Transfection Technologies Market, and What Factors Will Drive It?
In recent times, there has been substantial growth in the market size of transfection technologies. A rise from $1.21 billion in 2024 to $1.31 billion in 2025 is forecasted, showcasing a compound annual growth rate (CAGR) of 8.3%. The historical growth of this market is a reflection of the rising cases of chronic illnesses, the extended use of transfection technologies, the escalating demand for cell and gene therapy, increased investments in research and development, and a surge in cancer cases.
In the coming years, the transfection technologies market is poised for significant growth, expected to reach a value of $1.83 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.8%. The predicted growth in this timeframe is thanks to a number of factors: increasing rates of chronic and immunological diseases, an escalating need for cell-based treatments, a rise in the demand for protein production, expanding investments and funding dedicated to crafting drug delivery systems, and a surge in the demand for monoclonal antibodies. Key trends during this forecasted period involve increased R&D in cell-based therapy, the adoption of cutting-edge transfection methods, growing demand for innovative therapeutic delivery systems, escalating usage of dual-reporter assays and co-transfection experiments, and an intensified emphasis on personalized medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTransfection Technologies Market?
The surge in gene therapy is anticipated to act as a catalyst for the expansion of the transfection technologies market. It is a therapeutic method with a goal to cure or avert diseases by gene alterations which encompass insertion, repair, or replacement of defective genes. The boom in gene therapy is accelerated by advancements in genetic studies, improved delivery techniques, and its capacity to cure genetic disorders which were previously untreatable. Transfection technologies play a crucial role in gene therapy, enabling accurate, secure, and effective conveyance of genetic matter into cells. These technologies aid both temporary and permanent changes in the genome, which is vital for the treatment of genetic disorders and cancers. For example, in July 2023, as per the report revealed by the American Society of Gene & Cell Therapy (ASGCT), a professional organization based in the US, and Citeline, a drugs and appliances provider also based in the US, there were 247 gene therapies in Phase II at the end of quarter one (Q1) of 2023. This figure rose by 5 percent, touching 260 by the completion of quarter two (Q2). Hence, the surge in gene therapy is fuelling the expansion of the transfection technologies market.
Which Segments in the Transfection Technologies Offer the Most Growth?
The transfection technologies market covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTransfection Technologies Market?# Market?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Transfection Technologies Industry?
Leading organizations in the transfection technologies market are concentrating on the progression of high-tech systems, such as mechanoporation transfection methodologies, to promote intricate and personalized operations in research and therapeutic applications. Mechanoporation transfection strategies use mechanical effects to produce temporary holes in cell membranes, enabling genes to infiltrate cells. This approach is proficient and minimally intrusive, sustaining superior cell survival rates. For instance, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, unveiled CellPore, an inventive transfection system. The system comprises of a benchtop unit and the CellPore Transfection Kit 300, equipped with a specialized reagent bundle and one-time use delivery cartridges. By utilizing controlled, quick deformation in microfluidic channels, CellPore effectively delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing minimal cell disruption and improved survival rates. These elements are crucial for propelling research and introducing revolutionary cell and gene therapies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report
What Are the Key Elements That Define the Transfection Technologies Market?
Transfection technologies are the intentional introduction of nucleic acids into cells using chemical, physical, or biological methods to modify gene expression or genetic content. It is used to study gene function, produce proteins, silence genes via ribonucleic acid(RNA) interference (siRNA/miRNA), and potentially treat genetic diseases by introducing functional genes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model